Posts Categorized: Uncategorized

PHENOTIPS SECURES $2.5 MILLION CAD TO EXPAND REACH OF MEDICAL GENETICS SOFTWARE

UTEST startup PhenoTips has raised $2.5 million CAD in its first round of venture financing, as it looks to help healthcare providers prepare “for the imminent mainstreaming of genomic medicine.” The all-equity seed round, which closed earlier this month, was led by Toronto-based GreenSky Capital’s GreenSky Accelerator Fund IV. The round also saw participation from the Toronto… Read more »

UTEST 2021 APPLICATIONS OPEN!

The UTEST Program is announcing its tenth call for UofT companies. UTEST will provide UofT start-up companies with seed funding of up to $150,000 per company in the form of a SAFE, 12 months of incubation space*, intense entrepreneurial education provided by MaRS, corporate and intellectual property legal support, mentoring and business strategy support. Our program partner, TIAP, provides sector expertise, an Entrepreneurs-in-Residence (EIR)… Read more »

AmacaThera raises $10.3 million to develop post-surgery pain treatment: Globe and Mail

UTEST company, AmacaThera, born from the lab of renowned University of Toronto researcher Molly Shoichet has received $10.3 million from investors to begin human safety trials on an injectable gel that can improve post-surgery pain treatment, the Globe and Mail reports. AmacaThera is built on a gel technology developed by Shoichet, a University Professor in chemical engineering and applied chemistry and biomaterials and biomedical… Read more »

ACTO Acquires CoHealth!

ACTO, the Omnichannel Education and Engagement  platform for life sciences, today announced its acquisition of UTEST company, CoHealth, a mobile application that provides trusted resources for patients and caregivers. The deal is ACTO’s second strategic acquisition since securing $11.5 million this summer, and brings a new division with direct-to-patient education capabilities to ACTO’s SaaS platform. Founded in… Read more »

LegUp Computing Acquired by Microchip!

Microchip Technology Inc. (Nasdaq: MCHP) today announced it acquired UTEST company, LegUp Computing Inc., expanding its Field-Programmable Gate Array (FPGA)-based edge compute solution stack with a high-level synthesis (HLS) tool. Commercialized from University of Toronto research, the LegUp HLS tool will make it easier for a larger community of software engineers to harness the algorithm-accelerating power of… Read more »

PHENOMIC AI RAISES $7.97 MILLION CAD TO IDENTIFY PROMISING CANCER DRUGS

UTEST 2017 company, Phenomic AI, which aims to help researchers spot the differences between cells that could be early signs of disease and identify promising drugs, has raised $7.97 million CAD ($6 million USD) in financingThis latest round, which the Phenomic AI classified as seed financing, brings the company’s total raised to date to approximately… Read more »

UTEST 2020 COHORT APPLICATIONS OPEN!

UTEST is announcing its ninth call for UofT companies. UTEST provides UofT start-up companies with seed funding of up to $150,000 in the form of a SAFE, 12 months of incubation space*, intense entrepreneurial education provided by MaRS, corporate and intellectual property legal support, mentoring and business strategy support. Our program partner, TIAP, provides sector expertise, an Entrepreneurs-in-Residence (EIR) program and follow-on… Read more »

DEEP GENOMICS RAISES $40M SERIES B

UTEST 2015 cohort startup, Deep Genomics, has closed a $40 million Series B. This brings the company’s total funding to-date to $61 million. The round was led by Future Ventures and received investments from Amplitude Ventures, Khosla Ventures, Magnetic Ventures, and True Ventures. The financing will be put toward the development of treatments for rare genetic… Read more »

EBT Secures USD$10M Series A

EBT Medical, Inc., a 2018 UTEST company, is developing disruptive neuromodulation therapies for pelvic health disorders, recently secured a USD$10M Series A investment, co-led by two top-tier venture capital firms, SV Health Investors and Genesys Capital. EBT intends to use the funding to further develop its revolutionary noninvasive neuromodulation technology, as well as to pursue… Read more »